Pregnancy :: Pregnant women at risk for unnecessary operations due to misdiagnosis of appendicitis

New research published in the October issue of the Journal of the American College of Surgeons suggests that pregnant women suspected of having appendicitis are often misdiagnosed and undergo unnecessary appendectomies (removal of the appendix) that can result in early delivery or loss of the fetus. The study points to the need to require more accurate diagnosis to avoid unnecessary operations and the potential for fetal loss.

Urinary Tract Infection :: FDA approves new drug to treat complicated urinary tract and intra-abdominal infections

The U.S. Food and Drug Administration has approved doripenem injection, 500 mg intravenous infusion, for the treatment of complicated urinary tract and intra-abdominal infections. Doripenem injection, sold under the trade name Doribax, has been shown to be active against several strains of bacteria.

HIV :: FDA approves new HIV drug raltegravir tablets

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.